Randomized Trial of Specialty Palliative Care Integrated with Critical Care for Clinically Ill Older Adults at High Risk of Death or Severe Disability - Supplement
Randomized Trial of Specialty Palliative Care Integrated with Critical Care for Clinically Ill Older Adults at High Risk of Death or Severe Disability - Supplement
批准号:
10714105
负责人:
Yael Schenker
金额:
$39.45万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-15 至 2023-12-31
关键词:
AcademyAcuteAdministrative SupplementAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaAreaCaregiver supportCaregiversCaringCommunicationComplexCritical CareCritical IllnessDataElderlyEnhancement TechnologyFamilyFamily CaregiverGoalsGroup ProcessesHealthHospitalizationHospitalsInterventionLightMedicineMethodsOutcomePalliative CareParentsPatient CarePatient PreferencesPatient-Centered CarePatientsPhysiciansProviderQuality of CareResearch PersonnelSignal TransductionSpecialistTechnologyTraining ProgramsTreatment EfficacyWorkarmclinical caredisabilityefficacy evaluationend of lifeevidence basefunctional declinehigh riskhospital readmissionimprovedinnovationmedical specialtiesmortality riskolder patientpatient engagementpilot trialprogramsrandomized trialskill acquisitionskillsusability
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The National Academy of Medicine has identified improving clinicians’ serious illness
communication skills (SICS) as a priority area to improve patient and family outcomes near the end
of life. SICS are particularly important for hospitalized patients with moderate-to-severe Alzheimer’s
disease or related dementias (ADRD) because: 1) patients’ preferences vary substantially regarding
goals of care in this context; and 2) hospitalization often signals a worsening health trajectory with
cascading readmissions and functional decline, and therefore presents an opportunity to engage in
robust goals of care conversations. However, a critical barrier to achieving widespread
improvements in this aspect of care for hospitalized ADRD patients is the absence of a scalable,
empirically-validated way to help clinicians acquire the complex communication skills needed to
engage patients and families in goals of care discussions in the hospital setting.
The parent R01 on which this supplement builds is an RCT among critically ill older patients
assessing the efficacy of an intervention involving goals-of-care conversations delivered by palliative
care (PC) specialists to improve patient and family caregiver outcomes. The broad focus of both the
parent R01 and this ADRD supplement is on caregiver support and patient-centered care through
enhanced clinician-patient-caregiver communication. In light of the workforce shortages for PC
specialists, improving the skills of non-PC specialists, which is the goal of the supplement proposal,
is a critical strategy to increase care quality for hospitalized ADRD patients.
Our goal is to create and disseminate a technology-enhanced intervention that is both
scalable and empirically-validated to help hospital-based physicians and advanced practice
providers (APPs) acquire the skills needed to effectively conduct goals-of-care conversations for
hospitalized patients with ADRD and their families. Therefore, in Aim 1, we will use a nominal group
process to engage a diverse stakeholder panel in the construction of the technology-enhanced SICS
intervention for clinicians treating patients with ADRD. In Aim 2, we will conduct a single-arm pilot
trial to evaluate the feasibility, acceptability, and efficacy (i.e., skills acquisition) of the SICS
intervention.
The proposed work will have high impact because it will yield the preliminary data needed
for a successful R01 application to conduct an RCT to determine the impact of the scalable SICS
intervention on the outcomes of hospitalized patients with ADRD and their caregivers. The project is
innovative because it seeks to develop the first empirically-validated SICS intervention for clinicians
of patients with ADRD that leverages technology to achieve high scalability. The work is feasible in
our hands because we are a team of established investigators with a strong commitment to
improving patient and caregiver outcomes in ADRD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Midcareer Investigator Award in Patient-Oriented Research: Yael Schenker, MD, MAS
-
批准号:10390440
-
项目类别:
-
资助金额:$18.46万
-
财政年份:2021
-
负责人:Yael Schenker
-
依托单位:
Midcareer Investigator Award in Patient-Oriented Research: Yael Schenker, MD, MAS
-
批准号:10592288
-
项目类别:
-
资助金额:$18.46万
-
财政年份:2021
-
负责人:Yael Schenker
-
依托单位:
Randomized Trial of Specialty Palliative Care Integrated with Critical Care for Critically Ill Older Adults at High Risk of Death or Severe Disability
-
批准号:10663861
-
项目类别:
-
资助金额:$59.46万
-
财政年份:2020
-
负责人:Yael Schenker
-
依托单位:
Randomized Trial of Specialty Palliative Care Integrated with Critical Care for Critically Ill Older Adults at High Risk of Death or Severe Disability
-
批准号:10256820
-
项目类别:
-
资助金额:$60.63万
-
财政年份:2020
-
负责人:Yael Schenker
-
依托单位:
Randomized Trial of Specialty Palliative Care Integrated with Critical Care for Critically Ill Older Adults at High Risk of Death or Severe Disability
-
批准号:10437935
-
项目类别:
-
资助金额:$60.32万
-
财政年份:2020
-
负责人:Yael Schenker
-
依托单位:
Randomized Trial of Specialty Palliative Care Integrated with Critical Care for Critically Ill Older Adults at High Risk of Death or Severe Disability
-
批准号:10030184
-
项目类别:
-
资助金额:$62.88万
-
财政年份:2020
-
负责人:Yael Schenker
-
依托单位:
Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial
-
批准号:10401346
-
项目类别:
-
资助金额:$74.86万
-
财政年份:2019
-
负责人:Yael Schenker
-
依托单位:
Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial
-
批准号:10569584
-
项目类别:
-
资助金额:$38.96万
-
财政年份:2019
-
负责人:Yael Schenker
-
依托单位:
A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer
-
批准号:9103638
-
项目类别:
-
资助金额:$60.22万
-
财政年份:2016
-
负责人:Yael Schenker
-
依托单位:
A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer
-
批准号:9268708
-
项目类别:
-
资助金额:$58.78万
-
财政年份:2016
-
负责人:Yael Schenker
-
依托单位:
A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer
-
批准号:10164727
-
项目类别:
-
资助金额:$36.07万
-
财政年份:2016
-
负责人:Yael Schenker
-
依托单位:
A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer
-
批准号:10003009
-
项目类别:
-
资助金额:$44.21万
-
财政年份:2016
-
负责人:Yael Schenker
-
依托单位:
海外基金